HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated expression of activins promotes muscle wasting and cachexia.

Abstract
In models of cancer cachexia, inhibiting type IIB activin receptors (ActRIIBs) reverse muscle wasting and prolongs survival, even with continued tumor growth. ActRIIB mediates signaling of numerous TGF-β proteins; of these, we demonstrate that activins are the most potent negative regulators of muscle mass. To determine whether activin signaling in the absence of tumor-derived factors induces cachexia, we used recombinant serotype 6 adeno-associated virus (rAAV6) vectors to increase circulating activin A levels in C57BL/6 mice. While mice injected with control vector gained ~10% of their starting body mass (3.8±0.4 g) over 10 wk, mice injected with increasing doses of rAAV6:activin A exhibited weight loss in a dose-dependent manner, to a maximum of -12.4% (-4.2±1.1 g). These reductions in body mass in rAAV6:activin-injected mice correlated inversely with elevated serum activin A levels (7- to 24-fold). Mechanistically, we show that activin A reduces muscle mass and function by stimulating the ActRIIB pathway, leading to deleterious consequences, including increased transcription of atrophy-related ubiquitin ligases, decreased Akt/mTOR-mediated protein synthesis, and a profibrotic response. Critically, we demonstrate that the muscle wasting and fibrosis that ensues in response to excessive activin levels is fully reversible. These findings highlight the therapeutic potential of targeting activins in cachexia.
AuthorsJustin L Chen, Kelly L Walton, Catherine E Winbanks, Kate T Murphy, Rachel E Thomson, Yogeshwar Makanji, Hongwei Qian, Gordon S Lynch, Craig A Harrison, Paul Gregorevic
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 28 Issue 4 Pg. 1711-23 (Apr 2014) ISSN: 1530-6860 [Electronic] United States
PMID24378873 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cdkn1a protein, mouse
  • Cyclin-Dependent Kinase Inhibitor p21
  • Mstn protein, mouse
  • Muscle Proteins
  • Myostatin
  • activin A
  • activin B
  • Activins
  • Fbxo32 protein, mouse
  • SKP Cullin F-Box Protein Ligases
  • Activin Receptors, Type II
  • activin receptor type II-B
Topics
  • Activin Receptors, Type II (genetics, metabolism)
  • Activins (blood, genetics, metabolism)
  • Animals
  • Blotting, Western
  • Cachexia (genetics, metabolism)
  • Cell Line, Tumor
  • Cyclin-Dependent Kinase Inhibitor p21 (genetics, metabolism)
  • Dependovirus (genetics)
  • Gene Expression
  • Genetic Vectors (genetics)
  • Humans
  • MCF-7 Cells
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Muscle Proteins (genetics, metabolism)
  • Muscle, Skeletal (metabolism, pathology)
  • Muscular Atrophy (genetics, metabolism)
  • Myostatin (deficiency, genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • SKP Cullin F-Box Protein Ligases (genetics, metabolism)
  • Signal Transduction (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: